Oracea

Oracea Capsules: Effective Treatment for Papulopustular Rosacea

Oracea Capsules are the only FDA-approved oral treatment for papulopustular rosacea. These capsules are designed to provide a timed-release dose of doxycycline, ensuring sustained anti-inflammatory effects throughout the day. The unique formulation includes 30 mg of immediate-release doxycycline and 10 mg of delayed-release doxycycline, making it just as powerful as a 100 mg dose of doxycycline without crossing the antimicrobial threshold.

Key Benefits:

• Superior GI Tolerability: Unlike other forms of doxycycline, Oracea Capsules do not induce symptoms of nausea, diarrhea, or vomiting, making them easier to tolerate for long-term use.
• Convenient and Safe: The once-daily dose promotes patient adherence to treatment and keeps patients safely below the antibiotic threshold, reducing the risk of bacterial resistance.
• Visible Results: Oracea Capsules are effective in treating the inflammatory lesions of rosacea, providing visible results in maintaining clearer skin.

Why Choose Oracea Capsules?

• Unique Formulation: The combination of immediate and delayed release beads ensures that the medication is delivered effectively and safely.
• Suitable for Long-Term Use: Oracea Capsules are designed to be used over an extended period without compromising on strength or safety.
• No Evidence of Bacterial Resistance: In a 9-month clinical study, there was no evidence of bacterial resistance, making it a reliable choice for treating rosacea.

For patients with papulopustular rosacea, Oracea Capsules offer a convenient, safe, and effective solution. By choosing these capsules, you can help your patients achieve clearer skin and maintain treatment success over time.